Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
First-line therapy with axicabtagene ciloleucel induced objective responses in 89% of patients with high-risk large B-cell lymphoma, according to phase 2 study results.An estimated 91% of patients treated with a single infusion of the chimeric antigen receptor T-cell therapy remained alive at 12 months, a primary analysis of the ZUMA-12 trial showed.
Adults and children have different experiences with food protein-induced enterocolitis syndrome, although more research is necessary, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice. Specifically, unlike what has been document in the pediatric population, the adult cohort less frequently experienced vomiting, severe acute episodes and development of
SAN FRANCISCO — Results presented here showed anatomic-based medial collateral ligament repair and MCL reconstruction may be equivalent based on objective knee laxity, but MCL reconstruction had better subjective outcomes. Nicholas N. DePhillipo, PhD, ATC, and colleagues randomly assigned 54 patients with grade 3 MCL tears with or without concomitant ACL injuries to undergo either an
Peer-reviewed papers on pediatric antiphospholipid syndrome do not appear very often.However, when they do, they can be incredibly useful for rheumatologists who find themselves trying to diagnose and manage a patient with this rare and complicated condition, which can present in myriad ways.
The FDA has granted De Novo authorization for NeuroMetrix to market its Quell neuromodulation device as an aid for reducing fibromyalgia symptoms in adults with high pain sensitivity, according to a company press release.“There is an unmet need for effective and safe fibromyalgia treatments,” Shai N. Gozani, MD, PhD, CEO of NeuroMetrix, said in the release. “Receiving this De